U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07420816) titled 'Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder' on Feb. 06.
Brief Summary: The purpose of this study is to evaluate the efficacy of APSTZD compared to one active drug and placebo in insomnia treatment.
Study Start Date: March 26
Study Type: INTERVENTIONAL
Condition:
Insomnia
Insomnia Chronic
Intervention:
DRUG: APSTZD 1
APSTZD + placebo test 2 + placebo test 3 + placebo test 4 + comparator placebo 1
DRUG: APSTZD 2
APSTZD + placebo test 1 + placebo test 3 + placebo test 4 + comparator placebo 1
DRUG: APSTZD 3
APSTZD + placebo test 1 + placebo test 2 + placebo test 4 + comparator placebo 1
DRUG: APSTZD...